Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.08, $0.02 worse than the analyst estimate of $2.10. Revenue for the quarter came in at $1.95 billion versus the consensus estimate of $1.95 billion.

GUIDANCE:

Zimmer Biomet Holdings sees Q3 2017 EPS of $1.72-$1.77, versus the consensus of $1.95. Zimmer Biomet Holdings sees Q3 2017 revenue of $1.815-1.845 billion, versus the consensus of $1.86 billion.

Zimmer Biomet Holdings sees FY2017 EPS of $8.20-$8.30, versus the consensus of $8.51. Zimmer Biomet Holdings sees FY2017 revenue of $7.8-7.87 billion, versus the consensus of $7.86 billion.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.